Open Access

Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells

  • Authors:
    • Jun Lu
    • Jian Chen
    • Yani Kang
    • Jun Wu
    • Hui Shi
    • Yanli Fu
    • Lijing Jiao
    • Changsheng Dong
    • Xiaowei Li
    • Yu Jin
    • Wei Zhao
    • Ling Xu
    • Xiaodong Zhao
  • View Affiliations

  • Published online on: July 16, 2018     https://doi.org/10.3892/ol.2018.9149
  • Pages: 4343-4352
  • Copyright: © Lu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The traditional Chinese medicine Jinfukang (JFK) has been shown as a valuable drug to treat non‑small cell lung cancer (NSCLC). Previously, it was reported that JFK‑induced epigenetic alteration is involved in anti‑lung cancer activity. In the present study, the effect of JFK on lung cancer cell lines was examined with the aim to further understand the underlying mechanisms of JFK‑induced anti‑lung cancer activity by transcriptome profiling analysis. JFK was observed to decrease lung cancer cell viability and simultaneously induce cellular morphology alteration. Additionally, this causes cell cycle arrest and apoptosis in A549 cells. The present RNA‑seq analysis identified 5,281 genes with differential expression (P<0.05). Gene ontology analysis indicated that genes involved in the cell cycle pathway are downregulated, including cyclin‑dependent kinase 2, cyclin‑dependent kinase 4, cyclin B1 and cyclin A2, and apoptosis‑associated genes are upregulated, including Fas, death receptor 4 (DR4), tumor protein P53 binding protein 2 and BCL2 interacting protein 3 like. Particularly, the present results indicate knockdown of Fas and DR4 attenuates JFK‑induced apoptosis in A549 cells. Overall, the present study suggests JFK induces cellular apoptosis through activation of Fas and DR4 in A549 cells and provides an insight for understanding the antitumor mechanisms of this Chinese traditional medicine.
View Figures
View References

Related Articles

Journal Cover

October-2018
Volume 16 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lu J, Chen J, Kang Y, Wu J, Shi H, Fu Y, Jiao L, Dong C, Li X, Jin Y, Jin Y, et al: Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells. Oncol Lett 16: 4343-4352, 2018
APA
Lu, J., Chen, J., Kang, Y., Wu, J., Shi, H., Fu, Y. ... Zhao, X. (2018). Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells. Oncology Letters, 16, 4343-4352. https://doi.org/10.3892/ol.2018.9149
MLA
Lu, J., Chen, J., Kang, Y., Wu, J., Shi, H., Fu, Y., Jiao, L., Dong, C., Li, X., Jin, Y., Zhao, W., Xu, L., Zhao, X."Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells". Oncology Letters 16.4 (2018): 4343-4352.
Chicago
Lu, J., Chen, J., Kang, Y., Wu, J., Shi, H., Fu, Y., Jiao, L., Dong, C., Li, X., Jin, Y., Zhao, W., Xu, L., Zhao, X."Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells". Oncology Letters 16, no. 4 (2018): 4343-4352. https://doi.org/10.3892/ol.2018.9149